CGEN Stock Analysis: Buy, Sell, or Hold?
CGEN - Compugen Ltd
$2.62
-0.03 (-1.32%)
▼
5d:
+8.51%
30d:
+11.75%
90d:
+0.19%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 03, 2026
0d
Get Alerted When CGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CGEN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CGEN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CGEN is currently trading at $2.62, which is considered extended relative to its 30-day fair value range of $2.30 to $2.44.
Technical Outlook: Technically, CGEN is in a downtrend. Immediate support is located at $2.30, while resistance sits at $2.77.
Market Sentiment: CGEN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.60 (+75.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CGEN is in a downtrend. Immediate support is located at $2.30, while resistance sits at $2.77.
Market Sentiment: CGEN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.60 (+75.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.30 -
$2.44
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range (+7.2% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 75.9% below Wall St target ($4.60)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.30 -
$2.44
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.30
Resistance Level
$2.77
Current Trend
Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.13
Wall Street Target
$4.60
(+75.9%)
Revenue Growth (YoY)
107.0%
Profit Margin
47.6%
Share & Embed Analysis
Last updated: August 24, 2026 7:55 AM ET
Data refreshes hourly during market hours. Next update: 8:55 AM
Data refreshes hourly during market hours. Next update: 8:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Eran Ophir
SELL
5000 shares
2026-04-14
Zurit Levine
SELL
3125 shares
2026-04-10
Zurit Levine
SELL
5375 shares
2026-04-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 40 SELL |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
